Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
20.12
-0.51 (-2.47%)
Jun 9, 2026, 3:04 PM CST
SHE:002773 Market Cap
SHE:002773 has a market cap or net worth of 18.54 billion as of June 9, 2026. Its market cap has decreased by -21.89% in one year.
Market Cap
18.54B
Enterprise Value
11.80B
Revenue
4.43B
Ranking
n/a
PE Ratio
17.36
Stock Price
20.12
Market Cap Chart
Since June 26, 2015, SHE:002773's market cap has increased from 8.74B to 18.54B, an increase of 112.14%. That is a compound annual growth rate of 7.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 18.54B | -32.87% |
| Dec 31, 2025 | 27.61B | 53.16% |
| Dec 31, 2024 | 18.03B | 6.33% |
| Dec 29, 2023 | 16.95B | 17.53% |
| Dec 30, 2022 | 14.43B | -22.90% |
| Dec 31, 2021 | 18.71B | -57.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tasly Pharmaceutical Group | 20.90B |
| Betta Pharmaceuticals | 20.58B |
| Kangmei Pharmaceutical | 20.05B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 19.71B |
| Jilin Aodong Pharmaceutical Group | 19.37B |
| Guangdong Zhongsheng Pharmaceutical | 18.54B |
| Hybio Pharmaceutical | 18.18B |
| Walvax Biotechnology | 17.96B |